Authenticity and drug resistance in a panel of acute lymphoblastic leukaemia cell lines

British Journal of Cancer

Volumn 95, Issue 11, 2006, Pages 1537-1544

  Beesley, A H ^a   Palmer, M L ^a,b   Ford, J ^a   Weller, R E ^a   Cummings, A J ^a   Freitas, J R ^a   Firth, M J ^a   Perera, K U ^a   De Klerk, N H ^a   Kees, U R ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b CURTIN UNIVERSITY   (Australia)

Author keywords

Acute lymphoblastic leukaemia; Cell line; Drug resistance; Fingerprint; Glucocorticoid; Methotrexate

Indexed keywords

ASPARAGINASE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; GLUCOCORTICOID; MERCAPTOPURINE; METHOTREXATE; METHYLPREDNISOLONE; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER GROWTH; CANCER RELAPSE; CANCER RESISTANCE; CONTROLLED STUDY; DNA FINGERPRINTING; DRUG SENSITIVITY; HUMAN; HUMAN CELL; IC 50; LEUKEMIA CELL LINE; PHENOTYPE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CHILD; DNA FINGERPRINTING; DRUG RESISTANCE, NEOPLASM; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE;

EID: 33845243147     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603447     Document Type: Article

References (48)

1. Adamson PC, Poplack DG, Balis FM (1994) The cytotoxicity of thioguanine vs mercaptopurine in acute lymphoblastic leukemia. Leukemia Res 18: 805-810
2. Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR (1988) Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48: 589-601
3. Balis FM, Holcenberg JS, Poplack DG, Ge J, Sather HN, Murphy RF, Ames MM, Waskerwitz MJ, Tubergen DG, Zimm S, Gilchrist GS, Bleyer WA (1998) Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch study. Blood 92: 3569-3577
4. Catts VS, Farnsworth ML, Haber M, Norris MD, Lutze-Mann LH, Lock RB (2001) High level resistance to glucocorticoids associated with a dysfunctional glucocorticoid receptor in childhood acute lymphoblastic leukemia cells selected for methotrexate resistance. Leukemia 15: 929-935
5. Cooperman J, Neely R, Teachey DT, Grupp S, Choi JK (2004) Cell division rates of primary human precursor B cells in culture reflect in vivo rates. Stem Cells 22: 1111-1120
6. Drexler HG, Dirks WG, Matsuo Y, MacLeod RA (2003) False leukemia-lymphoma cell lines: an update on over 500 cell lines. Leukemia 17: 416-426
7. Drexler HG, Matsuo Y (1999) Guidelines for the characterization and publication of human malignant hematopoietic cell lines. Leukemia 13: 835-842
8. Drexler HG, Uphoff CC, Dirks WG, MacLeod RA (2002) Mix-ups and mycoplasma: the enemies within. Leukemia Res 26: 329-333
9. Duyn AE, Kaspers GJ, Pieters R, Van Zantwijk CH, Broekema GJ, Hahlen K, Veerman AJ (1999) Effects of interleukin 3, interleukin 7, and B-cell growth factor on proliferation and drug resistance in vitro in childhood acute lymphoblastic leukemia. Ann Hematol 78: 163-171
10. Fine BM, Kaspers GJ, Ho M, Loonen AH, Boxer LM (2005) A genome-wide view of the in vitro response to L-asparaginase in acute lymphoblastic leukemia. Cancer Res 65: 291-299
11. Hegge IR, Kaspers GJ, Rots MG, Jansen G, Pieters R, Veerman AJ (1999) Lack of cross-resistance between prednisolone and methotrexate in childhood acute lymphoblastic leukemia? A preliminary analysis. Adv Exp Med Biol 457: 551-555
12. Hirt A, Werren EM, Luethy AR, Gerdes J, Wagner HP (1992) Cell cycle analysis in lymphoid neoplasia of childhood: differences among immunologic subtypes and similarities in the proliferation of normal and leukaemic precursor B cells. Br J Haematol 80: 189-193
13. Holleman A, Den Boer ML, Kazemier KM, Janka-Schaub GE, Pieters R (2003) Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukaemia. Blood 102: 4541-4546
14. Kager L, Cheok M, Yang W, Zaza G, Cheng Q, Panetta JC, Pui CH, Downing JR, Relling MV, Evans WE (2005) Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics. J Clin Invest 115: 110-117
15. Kamb A (2005) What's wrong with our cancer models? Nat Rev Drug Discov 4: 161-165
16. Kaspers GJ, Pieters R, Van Zantwijk CH, Van Wering ER, Van Der Does-Van Den Berg A, Veerman AJ (1998) Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs. Blood 92: 259-266
17. Kaspers GJ, Veerman AJ, Pieters R, Van Zantwijk CH, Smets LA, Van Wering ER, Van Der Does-Van Den Berg A (1997) In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia. Blood 90: 2723-2729
18. Kaspers GJ, Wijnands JJ, Hartmann R, Huismans L, Loonen AH, Stackelberg A, Henze G, Pieters R, Hahlen K, Van Wering ER, Veerman AJ (2005) Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia. Eur J Cancer 41: 1300-1303
19. Kees UR (1987) Resistance to 1-beta-D-arabinofuranosylcytosine after high-dose treatment childhood lymphoblastic leukemia: isolation of a drug resistant and a sensitive cell line. Cancer Res 47: 3088-3091
20. Kees UR, Campbell LJ, Ford J, Willoughby ML, Peroni SE, Ranford PR, Garson OM (1995) New translocation t(2;13)(p12;q34) and rearrangement of the MLL gene in a childhood leukemia cell line. Genes Chromosomes Cancer 12: 201-208
21. Kees UR, Ford J, Dawson VM, Piall E, Aherne GW (1989a) Development of resistance to 1-beta-D-arabinofuranosylcytosine after high-dose treatment in childhood lymphoblastic leukemia: analysis of resistance mechanism in established cell lines. Cancer Res 49: 3015-3019
22. Kees UR, Ford J, Price PJ, Meyer BF, Herrmann RP (1987) PER-117: a new human ALL cell line with an immature thymic phenotype. Leukemia Res 11: 489-498
23. Kees UR, Ford J, Watson M, Murch A, Ringner M, Walker RL, Meltzer P (2003) Gene expression profiles in a panel of childhood leukemia cell lines mirror critical features of the disease. Mol Cancer Ther 2: 671-677
24. Kees UR, Lukeis R, Ford J, Garson OM (1989b) Establishment and characterization of a childhood T-cell acute lymphoblastic leukemia cell line, PER-255, with chromosome abnormalities involving 7q32-34 in association with T-cell receptor-beta gene rearrangement. Blood 74: 369-373
25. Kees UR, Lukeis R, Ford J, Willoughby ML, Garson OM (1990) Establishment and characterization of a childhood pre-B acute lymphoblastic leukemia cell line, PER-278, with chromosome translocations t(1;19) and t(1;9). Cancer Genet Cytogenet 46: 201-208
26. Kennedy MA, Gonzalez-Sarmiento R, Kees UR, Lampert F, Dear N, Boehm T, Rabbitts TH (1991) HOX11, a homeobox-containing T-cell oncogene on human chromosome 10q24. Proc Natl Acad Sci U S A 88: 8900-8904
27. Klumper E, Pieters R, Veerman AJ, Huismans DR, Loonen AH, Hahlen K, Kaspers GJ, van Wering ER, Hartmann R, Henze G (1995) In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia. Blood 86: 3861-3868
28. Kobayashi H, Takemura Y, Holland JF, Ohnuma T (1998) Vincristine saturation of cellular binding sites and its cytotoxic activity in human lymphoblastic leukemia cells: mechanism of inoculum effect. Biochem Pharmacol 55: 1229-1234
29. Lofgren C, Hjortsberg L, Blennow M, Lotfi K, Paul C, Eriksson S, Albertioni F (2004) Mechanisms of cross-resistance between nucleoside analogues and vincristine or daunorubicin in leukemic cells. Biochem Biophys Res Commun 320: 825-832
30. Martin-Aragon S, Mukherjee SK, Taylor BJ, Ivy SP, Fu CH, Ardi VC, Avramis VI (2000) Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs. Anticancer Res 20: 139-150
31. Masters JR (2000) Human cancer cell lines: fact and fantasy. Nat Rev Mol Cell Biol 1: 233-236
32. Masters JR, Thomson JA, Daly-Burns B, Reid YA, Dirks WG, Packer P, Toji LH, Ohno T, Tanabe H, Arlett CF, Kelland LR, Harrison M, Virmani A, Ward TH, Ayres KL, Debenham PG (2001) Short tandem repeat profiling provides an international reference standard for human cell lines. Proc Natl Acad Sci USA 98: 8012-8017
33. Medh RD, Webb MS, Miller AL, Johnson BH, Fofanov Y, Li T, Wood TG, Luxon BA, Thompson EB (2003) Gene expression profile of human lymphoid CEM cells sensitive and resistant to glucocorticoid-evoked apoptosis. Genomics 81: 543-555
34. Mihal V, Hajduch M, Noskova V, Janostakova A, Safarova M, Orel M, Kouzmina G, Stary J, Blazek B, Pospisilova D (2004) The analysis of correlations between drug resistance and clinical/laboratory measures found in a group of children with all treated by ALL-BFM 90 protocol. Bull Cancer 91: E80-E89
35. Pavek P, Merino G, Wagenaar E, Bolscher E, Novotna M, Jonker JW, Schinkel AH (2005) Human breast cancer resistance protein: interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b) pyridine, and transport of cimetidine. J Pharmacol Exp Ther 312: 144-152
36. Pieters R, den Boer ML, Durian M, Janka G, Schmiegelow K, Kaspers GJ, van Wering ER, Veerman AJ (1998) Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukaemia- implications for treatment of infants. Leukemia 12: 1344-1348
37. Pieters R, Huismans DR, Loonen AH, Hahlen K, van der Does-van den Berg A, van Wering ER, Veerman AJ (1991) Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia. Lancet 338: 399-403
38. Pieters R, Klumper E, Kaspers GJ, Veerman AJ (1997) Everything you always wanted to know about cellular drug resistance in childhood acute lymphoblastic leukemia. Crit Rev Oncol Hematol 25: 11-26
39. Pieters R, Loonen AH, Huismans DR, Broekema GJ, Dirven MW, Heyenbrok MW, Hahlen K, Veerman AJ (1990) In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions. Blood 76: 2327-2336
40. Ramakers-van Woerden NL, Pieters R, Loonen AH, Hubeek I, van Drunen E, Beverloo HB, Slater RM, Harbott J, Seyfarth J, van Wering ER, Hahlen K, Schmiegelow K, Janka-Schaub GE, Veerman AJ (2000) TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia. Blood 96: 1094-1099
41. Rots MG, Pieters R, Peters GJ, Noordhuis P, Van Zantwijk CH, Henze G, Janka-Schaub GE, Veerman AJ, Jansen G (2000) Methotrexate resistance in relapsed childhood acute lymphoblastic leukaemia. Br J Haematol 109: 629-634
42. Steinbach D, Friedrich J, Dawczynski K, Furchtbar S, Gruhn B, Wittig S, Zintl F, Sauerbrey A (2005) Are MTT assays the right tool to analyze drug resistance caused by ABC-transporters in patient samples? Leukemia Lymphoma 46: 1357-1363
43. Styczynski J, Pieters R, Huismans DR, Schuurhuis GJ, Wysocki M, Veerman AJ (2000) In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia. Br J Haematol 110: 813-818
44. Styczynski J, Wysocki M, Debski R, Balwierz W, Rokicka-Milewska R, Matysiak M, Balcerska A, Kowalczyk J, Wachowiak J, Sonta-Jakimczyk D, Chybicka A (2002) Cross-resistance to five glucocorticoids in childhood acute lymphoblastic and non-lymphoblastic leukemia samples tested by the MTT assay: preliminary report. Acta Biochim Pol 49: 93-98
45. Styczynski J, Wysocki M, Debski R, Czyzewski K, Balwierz W, Juraszewska E, Matysiak M, Malinowska I, Stanczak E, Sonta-Jakimczyk D, Szczepanski T, Wachowiak J, Konatkowska B, Balcerska A, Ploszynska A, Kowalczyk J, Stefaniak J, Badowska W, Wieczorek M, Olejnik I, Krawczuk-Rybak M, Kuzmicz M (2005) In vitro sensitivity of leukemic cells to nucleoside derivatives in childhood acute leukemias: good activity in leukemic relapses. Neoplasma 52: 74-78
46. van der Heijden J, de Jong MC, Dijkmans BA, Lems WF, Oerlemans R, Kathmann I, Scheffer GL, Scheper RJ, Assaraf YG, Jansen G (2004) Acquired resistance of human T cells to sulfasalazine: stability of the resistant phenotype and sensitivity to non-related DMARDs. Ann Rheum Dis 63: 131-137
47. Whitman SP, Strout MP, Marcucci G, Freud AG, Culley LL, Zeleznik-Le NJ, Mrozek K, Theil KS, Kees UR, Bloomfield CD, Caligiuri MA (2001) The partial nontandem duplication of the MLL (ALL1) gene is a novel rearrangement that generates three distinct fusion transcripts in B-cell acute lymphoblastic leukemia. Cancer Res 61: 59-63
48. Zwaan CM, Kaspers GJ, Pieters R, Ramakers-Van Woerden NL, den Boer ML, Wunsche R, Rottier MM, Hahlen K, van Wering ER, Janka-Schaub GE, Creutzig U, Veerman AJ (2000) Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia. Blood 96: 2879-2886